Chemoinformaics analysis of OBACUNONE-17-O-BETA-D-GLUCOSIDE
| Molecular Weight | 634.675 | nRot | 6 |
| Heavy Atom Molecular Weight | 592.339 | nRig | 34 |
| Exact Molecular Weight | 634.263 | nRing | 6 |
| Solubility: LogS | -3.357 | nHRing | 4 |
| Solubility: LogP | 1.742 | No. of Aliphatic Rings | 5 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 87 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 45 | No. of Aromatic Carbocycles | 0 |
| nHetero | 13 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 32 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 13 | No. of Arom Bond | 5 |
| nHA | 12 | APOL | 91.8713 |
| nHD | 5 | BPOL | 53.4187 |
| QED | 0.221 |
| Synth | 6.231 |
| Natural Product Likeliness | 2.764 |
| NR-PPAR-gamma | 0.937 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.706 |
| HIA | 0.954 |
| CACO-2 | -5.913 |
| MDCK | 0.00025254 |
| BBB | 0.234 |
| PPB | 0.791958 |
| VDSS | 0.461 |
| FU | 0.229013 |
| CYP1A2-inh | 0 |
| CYP1A2-sub | 0.107 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.447 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.065 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.075 |
| CYP3a4-inh | 0.052 |
| CYP3a4-sub | 0.066 |
| CL | 2.747 |
| T12 | 0.294 |
| hERG | 0.003 |
| Ames | 0.114 |
| ROA | 0.984 |
| SkinSen | 0.01 |
| Carcinogencity | 0.812 |
| EI | 0.005 |
| Respiratory | 0.972 |
| NR-Aromatase | 0.794 |
| Antiviral | Yes |
| Prediction | 0.851686 |